TNFSF11 and rheumatoid arthritis: The aim of the work was to assess serum concentration of OPG, RANKL, Dkk-1 and sclerostin in RA patients compared to a control group and to analyze changes of these concentrations during MTX therapy and in relation to achieved response to therapy.